| Literature DB >> 35211848 |
David Fluck1, Christopher Henry Fry2, Suzanne Rankin3, Andrea Lewis3, Jonathan Robin3, Jacqui Rees4, Jo Finch4, Yvonne Jones4, Gareth Jones4, Julia Tudose4, Liz Taylor4, Thang Sieu Han5,6.
Abstract
Uncertainties remain if changes to hospital care during the coronavirus disease (COVID-19) pandemic had an adverse impact on the care-quality of non-COVID-19 patients. We examined the association of hospital length of stay (LOS) with healthcare quality indicators in patients admitted with general medical conditions (non-COVID-19). In this retrospective monocentric study at a National Health Service hospital (Surrey), data were collected from 1st April 2019 to 31st March 2021, including the pandemic from 1st March 2020. Primary admissions, in-hospital mortality, post-discharge readmission and mortality were compared between the pre-pandemic (reference group) and pandemic period, according to LOS categories. There were 10,173 (47.7% men) from the pre-pandemic and 11,019 (47.5% men) from the pandemic period; mean (SD) age 68.3 year (20.0) and 68.3 year (19.6), respectively. During the pandemic, primary admission rates for acute cardiac conditions, pulmonary embolism, cerebrovascular accident and malignancy were higher, whilst admission rates for respiratory diseases and common age-related infections, and in-hospital mortality rates were lower. Amongst 19,721 survivors, sex distribution and underlying health status did not significantly differ between admissions before the pandemic and during wave-1 and wave-2 of the pandemic. Readmission rates did not differ between pre-pandemic and pandemic groups within the LOS categories of < 7 and 7-14 days, but were lower for the pandemic group who stayed > 14 days. For patients who died within seven days of admission, in-hospital mortality rates were lower in patients admitted during the pandemic. Mortality rates within 30 days of discharge did not differ between pre-pandemic and pandemic groups, irrespective of the initial hospital LOS. Despite higher rates of admission for serious conditions during the pandemic, in-hospital mortality was lower. Discharge time was similar to that for patients admitted before the pandemic, except it was earlier during the pandemic for those who stayed > 14 days, There were no group differences in quality-care outcomes.Entities:
Keywords: Charlson comorbidity index; Coronavirus; Length of stay; Mortality; Older age; Readmission
Mesh:
Year: 2022 PMID: 35211848 PMCID: PMC8869351 DOI: 10.1007/s11739-022-02945-7
Source DB: PubMed Journal: Intern Emerg Med ISSN: 1828-0447 Impact factor: 5.472
Characteristics of 21,192 patients admitted before and of those admitted during the COVID-19 pandemic
| Proportion of patients (%) | Group differences ( | ||
|---|---|---|---|
| Before pandemic ( | During pandemic ( | ||
| Age on admission (year) | |||
| 18–39 | 11.8 | 10.8 | 0.008 |
| 40–59 | 19.6 | 20.8 | |
| 60–79 | 32.9 | 33.7 | |
| ≥ 80 | 35.8 | 34.8 | |
| Sex | |||
| Men | 47.7 | 47.5 | 0.358 |
| Women | 52.3 | 52.5 | |
| Primary admissions | |||
| Acute coronary syndrome | 0.6 | 0.8 | 0.018 |
| Acute myocardial infarct | 3.7 | 4.2 | 0.021 |
| Pulmonary embolism | 1.1 | 1.4 | 0.022 |
| Cerebrovascular accident | 4.6 | 5.2 | 0.023 |
| Malignancy | 2.3 | 2.8 | 0.015 |
| Chronic obstructive pulmonary disease | 2.1 | 1.7 | 0.019 |
| Asthma | 1.2 | 0.6 | < 0.001 |
| Pneumonia | 10.0 | 5.1 | < 0.001 |
| Urinary tract infection | 4.9 | 4.3 | 0.015 |
| Sepsis | 1.8 | 1.3 | 0.001 |
| Congestive heart failure | 1.8 | 2.1 | 0.070 |
| Brain trauma | 1.0 | 0.8 | 0.161 |
| Inflammatory bowel disease | 0.8 | 0.7 | 0.398 |
| Gastrointestinal haemorrhage | 1.1 | 1.0 | 0.372 |
| Diabetes mellitus | 1.5 | 1.4 | 0. 358 |
| Charlson comorbidity index scores | |||
| 0 | 86.3 | 86.0 | 0.077 |
| 1 | 10.2 | 9.9 | |
| ≥ 2 | 3.5 | 4.1 | |
| Length of stay in hospital | |||
| < 7 days | 73.3 | 75.3 | < 0.001 |
| 7–14 days | 11.7 | 13.6 | |
| > 14 days | 15.0 | 111.1 | |
| Mortality in hospital | 7.6 | 6.0 | < 0.001 |
| Mortality within 30 days of discharge | 4.6 | 4.1 | 0.025 |
| Readmissions within 28 days of discharge | |||
| No readmission | 88.1 | 89.9 | < 0.001 |
| Single readmission | 9.1 | 7.7 | |
| ≥ 2 readmissions | 2.8 | 2.4 | |
Fig. 1.In-hospital mortality rates (A), readmission within 28 days (B), and mortality within 30 days (C) of hospital discharge, according to LOS amongst patients admitted before the pandemic and those admitted during the pandemic
Fig. 2.Distribution of readmissions at least once within 28 days of discharge amongst patients admitted before (A) and during the pandemic (B) according to age
Fig. 3.Distribution of mortality within 30 days of discharge amongst patients admitted before (A) and during the pandemic (B) according to age
Fig. 4.Distribution of age (A) and Charlson comorbidity index (B) at admission before, during wave-1 and wave-2 COVID-19 pandemic
Logistic regression to assess the risk of in-hospital mortality, post-discharge readmission and mortality amongst patients admitted during the pandemic compare to those admitted before the pandemic (reference group)
| In-hospital mortality | Risk from admission during COVID-19 pandemic compared to admission before the pandemic (reference group) | |||||
|---|---|---|---|---|---|---|
| Unadjusted | Adjusted for age, sex, CCI, and primary admissionsa | |||||
| OR | 95%CI | OR | 95%CI | |||
| LOS < 7 days | 0.79 | 0.68–0.93 | 0.005 | 0.80 | 0.67–0.95 | 0.010 |
| LOS = 7–14 days | 0.83 | 0.66–1.04 | 0.112 | 0.88 | 0.69–1.12 | 0.288 |
| LOS > 14 days | 0.85 | 0.69–1.04 | 0.109 | 0.92 | 0.75–1.14 | 0.462 |
| Readmitted within 28 days of discharge | OR | 95%CI | OR | 95%CI | ||
| LOS < 7 days | 0.95 | 0.84–1.08 | 0.417 | 0.95 | 0.84–1.08 | 0.466 |
| LOS = 7–14 days | 0.88 | 0.73–1.08 | 0.220 | 0.91 | 0.74–1.11 | 0.329 |
| LOS > 14 days | 0.68 | 0.56–0.82 | < 0.001 | 0.71 | 0.58–0.86 | < 0.001 |
| Mortality within 30 days of discharge | ||||||
| LOS < 7 days | 0.88 | 0.70–1.11 | 0.269 | 0.87 | 0.69–1.11 | 0.271 |
| LOS = 7–14 days | 1.05 | 0.81–1.37 | 0.700 | 1.05 | 0.80–1.38 | 0.718 |
| LOS > 14 days | 0.84 | 0.65–1.07 | 0.153 | 0.91 | 0.71–1.10 | 0.489 |
CCI, Charlson comorbidity index
aprimary admissions including 15 conditions presented in Table 1